Research News From April 20, 2016
advertisement
- Primary prevention of beta-cell autoimmunity and type 1 diabetes – The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives. Free full text available in HTML and PDF formats.
- Invokana increases rates of ketone-related adverse events in type 1 diabetes.
- Victoza Study in T1D Yields Inconsistent Results.